US3352904A - Nu-carboxyalkyl-(2-methylenealkanoyl) aniline compounds - Google Patents

Nu-carboxyalkyl-(2-methylenealkanoyl) aniline compounds Download PDF

Info

Publication number
US3352904A
US3352904A US348256A US34825664A US3352904A US 3352904 A US3352904 A US 3352904A US 348256 A US348256 A US 348256A US 34825664 A US34825664 A US 34825664A US 3352904 A US3352904 A US 3352904A
Authority
US
United States
Prior art keywords
mole
chloro
carboxyalkyl
lower alkyl
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US348256A
Inventor
John B Bicking
James M Sprague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to US348256A priority Critical patent/US3352904A/en
Priority to FR4435A priority patent/FR1458113A/en
Priority to GB5359/65A priority patent/GB1095236A/en
Priority to BR167298/65A priority patent/BR6567298D0/en
Priority to CH239265A priority patent/CH473090A/en
Priority to NL6502404A priority patent/NL6502404A/xx
Application granted granted Critical
Publication of US3352904A publication Critical patent/US3352904A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines

Definitions

  • the method for preparing the instant products consists in deaminating the Mannich amine precursors of the N- carboxyalkyl-(2-methylenealk;anoyl)aniline products by treating the said Mannich bases with a weak base or by subjecting them to pyrolysis.
  • This invention relates to a new class of N-carboxyalkyl-(Z-methylenealkauoyl) aniline compounds, the nontoxic, pharmacologically acceptable acid addition salts thereof and their amide derivatives.
  • the compounds of this invention exhibit highly valuable pharmacological properties which make them useful as diuretics. Thus, they are useful in the treatment of conditions resulting from an excessively high retention of fluid in the body or an excessively high concentration of electrolyte in the body, such as in the treatment of edematous conditions resulting, for example, from congestive heart failure.
  • N carboxyalkyl products of this invention the following structure:
  • Suitable groups illustrative of the radical R include, for example, methyl, ethyl, propyl, isopropyl, etc., cyclopentyl, cyclohexyl, 4-methylcyclohexyl, etc., 2,2,2-trifluoroethyl, 1- (trifluoromethyl)ethyl, etc., phenyl, 4-chlorophenyl, 4-
  • R groups include, for example, methyl, ethyl, propyl, etc., formyl, acetyl, etc.
  • Radicals illustrative of the X substituents include, for example, chlorine, bromine, etc., methyl, ethyl, propyl, etc., methoxy, ethoxy, etc.
  • R represents lower alkyl
  • R represents a member selected from the group consisting of hydrogen, lower alkyl and lower alkanoyl
  • X and X each represents similar or dissimilar radicals selected from the group consisting of hydrogen, halogen and lower alkyl
  • n represents an integer having a value of 1-2.
  • this invention also relates to the acid addition salts of the instant carboxylic acids, which salts are prepared by the reaction of the said carboxylic acids with a base having a non-toxic, pharmacologically acceptable cation.
  • any base which will form an acid addition salt with a carboxylic acid and whose pharmacological properties will not cause an adverse physiological etfect when ingested by the body system is considered as being within the scope of this invention; suitable bases thus include, for example, the alkali metal and alkaline earth metal hydroxides, carbonates, etc., ammonia, primary, secondary and tertiary amines, such as monoalkylamines, dialkylamines, trialkylamines, nitrogen containing heterocyclic amines, e.g., piperidine, etc.
  • the acid addition salts thus produced are the functional equivalents of the corresponding N-carboxyalkyl-(Z-methylenealkanoyl)aniline products and one skilled in the art will appreciate that to the extent that the carboxylic acids of the invention are useful in therapy, the variety of acid addition salts embraced by this invention are limited only by the criterion that the bases employed in forming the salts be both non-toxic and physiologically acceptable.
  • This invention also relates to the ester and amide derivatives of the N-carboxyalkyl-(Z-methylenealkanoyl) aniline compounds, which derivatives are prepared by conventional methods well-known to those skilled in the art.
  • the ester derivatives may be prepared by the reaction of the carboxylic acid product of the invention with an alcohol as, for example, with a lower alkyl alcohol to prepare the corresponding esterified derivative or, alternatively, converting the carboxylic acid product to its acid halide by conventional methods and treating the acid halide thus formed with the appropriate lower alkanol.
  • the amide derivatives of the instant N-carboxyalkyl-(Z-methylenealkanoyl) aniline products may be prepared by treating the acid halide of the instant acids with ammonia or an appropriate dialkylamine to produce the corresponding amide.
  • Still another process for preparing the said amide derivatives comprises treating the ester derivatives described supra with ammonia or an appropriate dialkylamine to produce the corresponding amide.
  • R, R X, m and n are as defined above, R and R each represents .a member selected from the group consisting of lower alkyl and, taken together with the nitrogen atom to which they are attached, a mononuclear heterocyclic ring such as pyrrolidino, piperidino, morpholino, etc. and HA represents an organic or inorganic acid capable of forming salts with amines, e.g., hydrochloric acid, etc., by treating the said Mannich derivative with a weak base, e.g., an aqueous sodium bicarbonate solution. Acidification of the resulting reaction mixture as, for example, with a suitable organic or inorganic acid, such as hydrochloric acid, separates out the desired N- carboxyalkyl-(2-methylenealkanoyDaniline compound.
  • a suitable organic or inorganic acid such as hydrochloric acid
  • the Mannich amine reagent (identified as compound II supra), wherein R represents a lower alkyl or lower alkanoyl substituent, is synthesized by the condensation of an N-carboXyalkyl-lower alkanoyl substituted aniline, or lower alkyl ester thereof, with formaldehyde or paraformaldehyde and. the acid addition salt of a secondary amine, for example, a di-lower alkylamine such as dimethylarnine, or a mononuclear heterocyclic amine as, for example, a pyrrolidine, piperidine, morpholine, etc.
  • a secondary amine for example, a di-lower alkylamine such as dimethylarnine, or a mononuclear heterocyclic amine as, for example, a pyrrolidine, piperidine, morpholine, etc.
  • the corresponding esterified product (ll) may, if desired, be hydrolyzed by conventional means to the desired acid.
  • the following equation illustrates the reaction:
  • R represents a member selected from the group consisting of lower alkyl and lower alkanoyl
  • R represents a member selected from the group consisting of hydrogen and loweralkyl, e.g., methyl, ethyl, etc.
  • w represents an integer having a value of 1 or a number greater than 1
  • HA represents an organic or inorganic acid capable of forming acid addition salts with amines, e.g., hydrochloric acid.
  • the Mannich amine reagent (II) wherein R represents hydrogen is prepared by the alternative reaction of an N-formyl-N-carboxyalkyl substituted aniline compound, i.e., a compound of the Formula 111 wherein the radical R represents formyl, with formaldehyde or paraformaldehyde and the acid addition salt of a secondary amine, followed by the treatment of the Mannich amine thus produced with hydrochloric acid to split otf the formyl group.
  • the treatment of the Mannich amine with the said hydrochloric acid is conveniently conducted with slight heating as, for example, on the steam bath for a short interval.
  • NcarboXyalkyl-nuclear alkanoyl substituted aniline compounds depicted as intenmediate 1H supra, are either known compounds or may be prepared by methods wellknown to those having ordinary skill in the art.
  • an N-lower alkanoyl substituted aniline depicted as compound VI infra, may be reacted with a suitable alkanoyl halide of the formula:
  • radical R is as described above and X reppresents halogen, e.g., chlorine, bromine, etc., in the presence of aluminum chloride to produce an N-alkanoylnuclear acylated aniline derivative (V), and the compound thus formed is hydrolyzed in aqueous hydrochloric acid solution to produce the corresponding nuclear acylated aniline intermediate (IV); which intermediate is then reacted with a suitable alkyl haloalkanoate, e.g., ethyl brornoaikanoate, in the presence of a base, such as anhydrous sodiunrcarbonate, to yield the corresponding alkyl N-carboxyalkyl-nuclear alkanoyl substituted aniline compound (Hi).
  • the said alkyl ester derivative (III) may be hydrolyzed to the corresponding carboxylic acid by treating the said ester (III) with an aqueous solution of sodium hydroxide.
  • R represents lower alkyl, e.g., methyl, ethyl, etc.
  • X represents halogen, e.g., chlorine, bromine, etc.
  • the N-loWer alkyl and N-lower alkanoyl substituted derivatives of the N-carboxyalkyl-nuclear acylated aniline intermediate (Hi) may be prepared by treating the latter with a suitable alkylating agent, e.g., dimethyl sulfate, diethyl sulfate, etc., or an appropriate acylating agent, e.g., acetic anhydride, etc.
  • a suitable alkylating agent e.g., dimethyl sulfate, diethyl sulfate, etc.
  • an appropriate acylating agent e.g., acetic anhydride, etc.
  • N-carboxyalkyl (2 methylenealkanoyl)aniline products of this invention are generally obtained as solids and, if desired, may be purified by recrystallization from a suitable solvent, e.g., ethyl acetate or isopropyl alcohol.
  • This product is collected and hydrolyzed by heating with 900 ml. of 6 N hydrochloric acid for 1.5 hours on the steam bath and the solution thus obtained is made basic with a 40% sodium hydroxide solution.
  • the product is collected and recrystallized from isopropyl alcohol to obtain 77 g. of 2'-ch1oro- 4'-aminopropiophenone, M.P. 97-101 C.
  • the benzene solution is then evaporated in vacuo, the residual oil is dissolved in a mixture of 50 ml. of 10% sodium hydroxide solution and 30 ml. of ethanol and the solution refluxed for 10 minutes. Water (200 ml.) is added and the solution acidified With hydrochloric acid to precipitate the product, which is recrystallized from aqueous isopropyl alcohol to obtain 4.0 g. of
  • the solution is evaporated to dryness in vacuo and the residue is hydrolyzed by heating for 3 minutes on the steam bath in a boiling mixture of 300 ml. of sodium hydroxide solution and 100 ml. of ethanol.
  • the solution is acidified with hydrochloric acid to precipitate the product and then recrystallized from aqueous isopropyl alcohol to obtain 35.5 g. of N-(3-chloro-4-propionylphenyl)-N-acetylglycine, MP. 151153 C.
  • the compound N'[3-chloro-4-(2-di methylarninomethylpropionyl)phenyl] N-acetylglycine hydrochloride forms and spontaneously decomposes during the heating period to a melt comprising the compound N (3 chloro-4-methacryloylphenyi)-N-acetylglycine.
  • the melt is dissolved in boiling aqueous isopropyl alcohol and the resulting solution is then chilled to precipitate the product.
  • the product is recrystallized from isopropyl alcohol to yield 1.8 g. of N-(3-ch1oro-4-methacryloylphenyl)-N-acetylglycine, MP. l76.5179 C.
  • STEP B --N-(4-PROPIONYLPHENYL) N- ACETYLGLYCINE
  • N-(4-propionylphenyl)-N-acetylglycine 12.5 g. (0.05 mole) of N-(4-propionylphenyl)-N-acetylglycine, 2.1 g. (0.07 mole) of paraforrnaldehyde, 4.5 g. (0.055 mole) of dimethylamine hydro-,
  • N-carboxyalkyl-4-(2- sec.-aminomethylalkanoyl)aniline hydrochloride reactant (II) for the N-[3-chloro-4-(Z-dimethylaminomethylpropionyl)phenyl]sarcosine hydrochloride of Example 2, Step C, and following substantially the procedure described therein, the corresponding N-carboxyalkyl-(Z- methylenealkanoyl)aniline products are prepared.
  • the following equation and accompanying table depict the reaction described in the foregoing example and illustrate the starting materials and final products produced thereby:
  • N carboxyalkyl (2 methylenea'lkanoyl)aniline compounds of the present invention constitute a very valuable class of compounds which has not been prepared heretofore.
  • processes disclosed in the above examples are merely illustrative and are capable of wide variation and modification without departing from the spirit of this invention.
  • R represents a member selected from the group consisting of lower alkyl, cycloalkyl, trifluoromethyl sub stituted lower alkyl,
  • X011m (X0111 and wherein the radical X is a member selected from the group consisting of hydrogen, halogen, lower alkyl and lower alkoxy, R is a member selected from the group consisting of hydrogen, lower alkyl and lower alkanoyl, X is a member selected from the group consisting of H M L f El base lgiydrogen, halogen, lower alkyl and, taken together, two N CDHEH OOH 3O radicals on ad acent carbon atoms of the benzene ring 5 may be combined to form an hydrocarbylene chain contaming four carbon atoms between their points of attach- N HCl ment, m, in each occurrence, is an integer having a value of 13 and n, in each occurrence, is an integer having a 1 value of 1-5.
  • R represents lower alkyl
  • R is a member selected from the group consisting of hydrogen, lower alkyl and lower alkanoyl
  • X and X each represents similar or dissimilar radicals selected from the group consisting of hydrogen, halogen and lower.
  • alkyl and n is an integer having a value of 1-2.
  • R is lower alkyl
  • X is halogen
  • n is an integer having a value of 1-2.
  • R is lower alkyl, R is lower alkanoyl, X is halogen and n is an integer having a value of 1-2.
  • R o n-o-o r ronnnii o H wherein R is lower alkyl, R is lower alkanoyl and n is an integer having a value of 1-2.
  • R is lower alkyl
  • X and X represent lower alkyl
  • n is an integer having a value of 1-2.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

United States Patent Cfifice 3,352,964 Patented Nov. 14, 1967 ABSTRACT OF THE DISCLOSURE N-carboxyalkyl-(Z-methylenealkanoyl)anilines which may be substituted at the nitrogen atom 'by an alkyl or lower alkanoyl radical. The products are diuretic and saluretic agents which are useful in the treatment of conditions associated with edema.
The method for preparing the instant products consists in deaminating the Mannich amine precursors of the N- carboxyalkyl-(2-methylenealk;anoyl)aniline products by treating the said Mannich bases with a weak base or by subjecting them to pyrolysis.
This invention relates to a new class of N-carboxyalkyl-(Z-methylenealkauoyl) aniline compounds, the nontoxic, pharmacologically acceptable acid addition salts thereof and their amide derivatives.
The compounds of this invention exhibit highly valuable pharmacological properties which make them useful as diuretics. Thus, they are useful in the treatment of conditions resulting from an excessively high retention of fluid in the body or an excessively high concentration of electrolyte in the body, such as in the treatment of edematous conditions resulting, for example, from congestive heart failure.
The N carboxyalkyl products of this invention the following structure:
(2 methylenealkanoyl)aniline relate to a compound having wherein R is a member selected from the group consisting of lower alkyl, cycloalkyl, e.g., cycloalkyl radicals containing 5-6 nuclear carbon atoms, trihalomethyl-lower alkyl,
and OnHBIJ wherein X represents a member selected from the group consisting of hydrogen, halogen, lower alkyl and lower alkoxy, R represents a member selected from the group consisting of hydrogen, lower alkyl, and lower alkanoyl, X represents a member selected from the group consisting of hydrogen, halogen, lower alkyl and, taken together, two X radicals on adjacent carbon atoms of the benzene nucleus may be joined to form an hydrocarbylene chain (i.e., a divalent organic radical composed solely of carbon and hydrogen) containing four carbon atoms between their points of attachment, e.g., 1,3-butadienylene, i.e., --CH=CHCH=CH, etc., In, in each occurrence, is an integer having a value of 1-3 and n, in each occurrence, is an integer having a value of 1-5. Suitable groups illustrative of the radical R include, for example, methyl, ethyl, propyl, isopropyl, etc., cyclopentyl, cyclohexyl, 4-methylcyclohexyl, etc., 2,2,2-trifluoroethyl, 1- (trifluoromethyl)ethyl, etc., phenyl, 4-chlorophenyl, 4-
tolyl, etc., benzyl, 4-chlorobenzyl, 4-methoxybenzyl, etc., R groups include, for example, methyl, ethyl, propyl, etc., formyl, acetyl, etc. Radicals illustrative of the X substituents include, for example, chlorine, bromine, etc., methyl, ethyl, propyl, etc., methoxy, ethoxy, etc.
A preferred embodiment of the invention relates to a compound of the following formula:
wherein the radical R represents lower alkyl, R represents a member selected from the group consisting of hydrogen, lower alkyl and lower alkanoyl, X and X each represents similar or dissimilar radicals selected from the group consisting of hydrogen, halogen and lower alkyl and n represents an integer having a value of 1-2. The above-described class of compounds are particularly valuable diuretic agents and are thus highly useful in the treatment of conditions associated with electrolyte and fluid retention.
In addition to the N-carboxyalkyl-(2rnethylenealkanoyl)aniline products described above this invention also relates to the acid addition salts of the instant carboxylic acids, which salts are prepared by the reaction of the said carboxylic acids with a base having a non-toxic, pharmacologically acceptable cation. In general, any base which will form an acid addition salt with a carboxylic acid and whose pharmacological properties will not cause an adverse physiological etfect when ingested by the body system is considered as being within the scope of this invention; suitable bases thus include, for example, the alkali metal and alkaline earth metal hydroxides, carbonates, etc., ammonia, primary, secondary and tertiary amines, such as monoalkylamines, dialkylamines, trialkylamines, nitrogen containing heterocyclic amines, e.g., piperidine, etc. The acid addition salts thus produced are the functional equivalents of the corresponding N-carboxyalkyl-(Z-methylenealkanoyl)aniline products and one skilled in the art will appreciate that to the extent that the carboxylic acids of the invention are useful in therapy, the variety of acid addition salts embraced by this invention are limited only by the criterion that the bases employed in forming the salts be both non-toxic and physiologically acceptable.
This invention also relates to the ester and amide derivatives of the N-carboxyalkyl-(Z-methylenealkanoyl) aniline compounds, which derivatives are prepared by conventional methods well-known to those skilled in the art. Thus, for example, the ester derivatives may be prepared by the reaction of the carboxylic acid product of the invention with an alcohol as, for example, with a lower alkyl alcohol to prepare the corresponding esterified derivative or, alternatively, converting the carboxylic acid product to its acid halide by conventional methods and treating the acid halide thus formed with the appropriate lower alkanol. Similarly, the amide derivatives of the instant N-carboxyalkyl-(Z-methylenealkanoyl) aniline products may be prepared by treating the acid halide of the instant acids with ammonia or an appropriate dialkylamine to produce the corresponding amide. Still another process for preparing the said amide derivatives comprises treating the ester derivatives described supra with ammonia or an appropriate dialkylamine to produce the corresponding amide. These and other equivalent methods for the preparation of the ester and amide derivatives of the instant N-carboxyalkyl-(Z-methylenealkanoyl)aniline products will be apparent to one having ordinary skill in the art and to the extent that the said derivatives are both non-toxic and physiologically acceptable to the body system the said esters and amides are the functional equivalents of the corresponding carboxylic acid products.
The products of the invention are conveniently prepared by the deamination of a Mannich amine compound of the formula:
wherein R, R X, m and n are as defined above, R and R each represents .a member selected from the group consisting of lower alkyl and, taken together with the nitrogen atom to which they are attached, a mononuclear heterocyclic ring such as pyrrolidino, piperidino, morpholino, etc. and HA represents an organic or inorganic acid capable of forming salts with amines, e.g., hydrochloric acid, etc., by treating the said Mannich derivative with a weak base, e.g., an aqueous sodium bicarbonate solution. Acidification of the resulting reaction mixture as, for example, with a suitable organic or inorganic acid, such as hydrochloric acid, separates out the desired N- carboxyalkyl-(2-methylenealkanoyDaniline compound.
The Mannich amine reagent (identified as compound II supra), wherein R represents a lower alkyl or lower alkanoyl substituent, is synthesized by the condensation of an N-carboXyalkyl-lower alkanoyl substituted aniline, or lower alkyl ester thereof, with formaldehyde or paraformaldehyde and. the acid addition salt of a secondary amine, for example, a di-lower alkylamine such as dimethylarnine, or a mononuclear heterocyclic amine as, for example, a pyrrolidine, piperidine, morpholine, etc. When the starting material employed is the lower alkyl ester of N-carboXy-lower alkyl aniline, i.e., when R in the compound depicted as III infra represents a lower alkyl group, the corresponding esterified product (ll) may, if desired, be hydrolyzed by conventional means to the desired acid. The following equation illustrates the reaction:
(X)m i wherein the radicals R, R R X, m and n are as defined above, R represents a member selected from the group consisting of lower alkyl and lower alkanoyl, R represents a member selected from the group consisting of hydrogen and loweralkyl, e.g., methyl, ethyl, etc. and w represents an integer having a value of 1 or a number greater than 1 and HA represents an organic or inorganic acid capable of forming acid addition salts with amines, e.g., hydrochloric acid. The Mannich amine reagent (II) wherein R represents hydrogen is prepared by the alternative reaction of an N-formyl-N-carboxyalkyl substituted aniline compound, i.e., a compound of the Formula 111 wherein the radical R represents formyl, with formaldehyde or paraformaldehyde and the acid addition salt of a secondary amine, followed by the treatment of the Mannich amine thus produced with hydrochloric acid to split otf the formyl group. The treatment of the Mannich amine with the said hydrochloric acid is conveniently conducted with slight heating as, for example, on the steam bath for a short interval.
The NcarboXyalkyl-nuclear alkanoyl substituted aniline compounds, depicted as intenmediate 1H supra, are either known compounds or may be prepared by methods wellknown to those having ordinary skill in the art. Thus, an N-lower alkanoyl substituted aniline, depicted as compound VI infra, may be reacted with a suitable alkanoyl halide of the formula:
wherein the radical R is as described above and X reppresents halogen, e.g., chlorine, bromine, etc., in the presence of aluminum chloride to produce an N-alkanoylnuclear acylated aniline derivative (V), and the compound thus formed is hydrolyzed in aqueous hydrochloric acid solution to produce the corresponding nuclear acylated aniline intermediate (IV); which intermediate is then reacted with a suitable alkyl haloalkanoate, e.g., ethyl brornoaikanoate, in the presence of a base, such as anhydrous sodiunrcarbonate, to yield the corresponding alkyl N-carboxyalkyl-nuclear alkanoyl substituted aniline compound (Hi). If desired, the said alkyl ester derivative (III) may be hydrolyzed to the corresponding carboxylic acid by treating the said ester (III) with an aqueous solution of sodium hydroxide. The following equation illus.
base
wherein the radicals R, X, X, m and n are as defined above R represents lower alkyl, e.g., methyl, ethyl, etc., and X represents halogen, e.g., chlorine, bromine, etc. If desired, the N-loWer alkyl and N-lower alkanoyl substituted derivatives of the N-carboxyalkyl-nuclear acylated aniline intermediate (Hi) may be prepared by treating the latter with a suitable alkylating agent, e.g., dimethyl sulfate, diethyl sulfate, etc., or an appropriate acylating agent, e.g., acetic anhydride, etc.
The N-carboxyalkyl (2 methylenealkanoyl)aniline products of this invention are generally obtained as solids and, if desired, may be purified by recrystallization from a suitable solvent, e.g., ethyl acetate or isopropyl alcohol.
The following examples are illustrative of the N-carboxyalkyl-(2-rnethylenealkanoyl)aniline products of the invention and the methods by which they may be prepared. The examples are illustrative only and the in vention should not be construed as being limited thereto.
EXAMPLE 1 N-(3-chl0r0-4-methacryloylphenyl)glycine STEP A.2'-CHLORO-4-AMINOPROPIOPHENONE 3-chloropropionanilide (172 g., 0.94 mole) is mixed with 504 g. (3.76 mole) of aluminum chloride. Propionyl chloride (175 g., 1.88 mole) is then added to the mixture with stirring over a 4 hour period and the mixture is stirred for 3 hours While heating on a steam bath. The mixture is then poured onto a mixture of ice and hydrochloric acid and the 3-chloro-4-propionylpropionanilide separates out by crystallization. This product is collected and hydrolyzed by heating with 900 ml. of 6 N hydrochloric acid for 1.5 hours on the steam bath and the solution thus obtained is made basic with a 40% sodium hydroxide solution. The product is collected and recrystallized from isopropyl alcohol to obtain 77 g. of 2'-ch1oro- 4'-aminopropiophenone, M.P. 97-101 C.
An analytical sample of 2'-chloro-4-aminopropiophenone gives a M.P. of 98101 C.
Analysis for C H ClNO.Calculated: C, 58.86; H, 5.49; N, 7.63. Found: C, 58.76; H, 5.38; N, 7.55.
STEP B.-ETHYL IN-(3-CHLORO-4-PROPIONYLPHENYL) GLYCI-NATE A mixture of 9.2 g. (0.05 mole) of 2'-chloro-4'-aminopropiophenone, 9.2 g. (0.055 mole) of ethyl bromoacetate, 10.6 g. (0.1 mole) of anhydrous sodium carbonate and 30 ml. of ethanol is refluxed for 18 hours. The inorganic salts are filtered 01? and the filtrate diluted with 50 ml. of water to precipitate the product, which is recrystallized twice from benzene to yield 6.7 g. of ethyl N-(3-chloro-4-propionylphenyl)glycinate, M.P. 8081.5 C.
Analysis for C H ClNO .Calculated: N, 5.19. Found: N, 5.13.
STEP C.N- 3-CHLOR OA-PROPIONYLPHENYL) GLYCINE A mixture of 27 g. (0.1 mole) of ethyl N-(3-chloro- 4-propionylphenyl)glycinate and 250 ml. of 5% sodium hydroxide solution is stirred and heated for 20 minutes on the steam bath. The resulting clear solution is acidified with hydrochloric acid to precipitate 23.5 g. of N-(3- chloro-4-propionylphenyDglycine, MP. 141-143 C.
Analysis for C H ClNO .Calculated: C, 54.66; H, 5.01; N, 5.80. Found: C, 54.67; H, 5.12; N, 5.73.
STEP D.N- (3#CHLORO-4PROPIONYLPHENYL) FORMYLGLYCINE A solution of 14.6 g. (0.06 mole) of N-(3-chloro-4 propionylphenyl)glycine in a mixture of ml. of formic acid and 25 m1. of acetic anhydride is allowed to stand one hour and then evaporated to dryness in vacuo. The residue is recrystallized from benzene to obtain 12.5 g. of N (3 chloro-4-propionylphenyl) N-formylglycine, M.P. 116118 C.
Analysis for C H ClNO .Calculated: C, 53.44; H, 4.49; N, 5.19. Found: C, 53.35; H, 4.60; N, 5.12.
STEP E.N- 3-CHLORO-4- (2-DIMETHYLAMINOMETHYL- PROPIONYL) PHENYL] 1N FORMYLGLY'CI-NE HYDRO- CHLORIDE A mixture of 8.1 g. (0.03 mole) of N-(3-ch1oro-4- propionylphenyl)N-formylglycine, 1.35 g. (0.045 mole) of pararormaldehyde, 2.7 g. (0.033 mole} of dimethylamine hydrochloride and 4 drops of acetic acid is heated for 40 minutes on the steam bath. The melt is dissolved in 40 ml. of boiling isopropyl alcohol and the resulting solution is chilled to precipitate 4.1 g. of N-[3-chloro-4- (2 dimethylaminomethylpropionyl)phenyl] N-formylglycine hydrochloride, M.P. 144-148" C.
STEP F.-N- 3-CHLORO-d-METHACRYLOYLPHENYL) GLYCINE N [3 chloro-4-(2-dimethylaminomethylpropionyl) henyH-N-formylglycine hydrochloride (4.0 g., 0.011 mole) is dissolved in 40 ml. of 5% hydrochloric acid solution and the solution heated for 5 minutes on the steam bath to produce N-[3-chloro-4-(2-dimethylaminomethylpropionyl) phenyl] glycine hydrochloride. Saturated sodium bicarbonate solution (160 ml.) is then added and heating continued for another 5-rninute period. The solution is then cooled and acidified to precipitate a crystalline product which is then recrystallized from ethyl acetate to obtain 1.1 g. of N-(3-chloro-4-methacryloylphenyl)glycine, M.P. 145-147 C.
Analysis for C H ClNO .-Calculated: C, 56.81; H, 4.77; N, 5.52. Found: C, 56.82; H, 4.62; N, 5.46.
EXAMPLE 2 N-(3-chl0r0-4-methacryloylphenyl)sarcosine STEP A.N- (3-CHL OR O4PR OPIONYLPHE'NYL) S ARCOSINE A mixture of 3.1 g. (0.03 mole) of ethyl N-(3-chloro- 4-propionylphenyl)glycinate, prepared as described in Example 1, Step B, 5.1 g. (0.04 mole) of dimethyl sulfate, 6.4 g. (0.06 mole) of sodium carbonate and 35 ml. of benzene is refluxed for 24 hours, cooled and extracted with Water. The benzene solution is then evaporated in vacuo, the residual oil is dissolved in a mixture of 50 ml. of 10% sodium hydroxide solution and 30 ml. of ethanol and the solution refluxed for 10 minutes. Water (200 ml.) is added and the solution acidified With hydrochloric acid to precipitate the product, which is recrystallized from aqueous isopropyl alcohol to obtain 4.0 g. of
-(3-chloro-4-propionylphenyl)sarcosine, M.P. 12l123 Analysis for C H ClNO .-Calculated: c, 56.36; H, 5.52; N, 5.48. Found: 0, 55.98; H, 5.57; N, 5.44.
STEP B.-N-[3-CHLORO-4 (2-DIMETHYLAMINOMETHYL- PR OPIOzNYL) -PHENYL] S ARCOSINE HYDROCHLORIDE A solution of 10 g. (0.0285 mole) of N-[3-cl11oro-4- (2 dimethylarninomethylpropionyl)phenyl]sarcosine hydrochloride in 70 ml. of saturated sodium bicarbonate solution is heated for 5 minutes on the steam bath. The solution is then cooled and acidified with hydrochloric acid. The product which precipitates is recrystallized twice from ethyl acetate to obtain 1.1 g. of N-(3-chloro- 4-methacryloylphenyl)sarcosine, M.P. 118119 C.
Analysis for C H ClNO .Calculated: C, 58.25; H, 5.27; N, 5.23. Found: C, 57.99; H, 5.36; N, 5.19.
EXAMPLE 3 N-(3-chl0r0-4-methaclyloylphenyl) -N-acetylglycine STEP A.N-(3CHLORO-4-PROPIONYLPHENYL) -N- ACETYLGLZCINE A solution of 72.5 g. (0.27 mole) of ethyl N-(3- chloro-4-propionylphenyl) glycinate, prepared by the method described in Example 1, Step B, in 91 g. (0.9 mole) of acetic anhydride is heated for 16 hours on the steam bath. The solution is evaporated to dryness in vacuo and the residue is hydrolyzed by heating for 3 minutes on the steam bath in a boiling mixture of 300 ml. of sodium hydroxide solution and 100 ml. of ethanol. The solution is acidified with hydrochloric acid to precipitate the product and then recrystallized from aqueous isopropyl alcohol to obtain 35.5 g. of N-(3-chloro-4-propionylphenyl)-N-acetylglycine, MP. 151153 C.
Analysis for C H .,ClNO .-Calculated: N, 4.94. Found: N, 4.87.
STEP B.tN- (3-CHLORO-d-METHACRYLOYLPHENYL) -N- ACETYLGLYCINE A mixture of 5.7 g. (0.02 mole) of N-(3-chloro-4- propionylphenyl)-Nracetylglycine, 0.84 g. (0.028 mole) of paraformaldehyde, 1.8 g. (0.022 mole) of dimethylamine hydrochloride and 1 ml. of acetic acid is heated for 1 hour at 110 C. The compound N'[3-chloro-4-(2-di methylarninomethylpropionyl)phenyl] N-acetylglycine hydrochloride forms and spontaneously decomposes during the heating period to a melt comprising the compound N (3 chloro-4-methacryloylphenyi)-N-acetylglycine. The melt is dissolved in boiling aqueous isopropyl alcohol and the resulting solution is then chilled to precipitate the product. The product is recrystallized from isopropyl alcohol to yield 1.8 g. of N-(3-ch1oro-4-methacryloylphenyl)-N-acetylglycine, MP. l76.5179 C.
Analysis for C H ClNG .-Calculated: C, 56.86; H, 4.77; N, 4.74. Found: C, 56.95; H, 4.83; N, 4.67.
EXAMPLE 4 N-(4-methacryloylplzenyl)-N-acctylglycine STEP A.ETHYL N(4-PROPIONYLPHENYL) GLYCINATE A mixture of 44.6 g. (0.3 mole) of 4'-aminopropiophenone, 55 g. (0.33 mole) of ethyl bromoacetate, 53 g.
(0.5 mole) of sodium carbonate and 180 ml. of. ethanol are refluxed for 17 hours. The solution is cooled and to the mixture is added 750 ml. of water. The product which separates is recrystallized from a mixture of benzenecyclohexane to obtain 59.5 g. of ethyl N-(4-propionylphenyUglyciuate, MP. 74-78 C. 78A5n analytical sample gives a melting point of 77- Analysis for C H NO .-Calculated: C, 66.36; H, 7.28; N, 5.95. Found: C, 66.31; H, 7.00; N, 5.88.
STEP B.--N-(4-PROPIONYLPHENYL) N- ACETYLGLYCINE A mixture of 12.5 g. (0.05 mole) of N-(4-propionylphenyl)-N-acetylglycine, 2.1 g. (0.07 mole) of paraforrnaldehyde, 4.5 g. (0.055 mole) of dimethylamine hydro-,
ill
chloride and 1 ml. of acetic acid is heated for /2 hour at -125 C. to produce the compound N-{4-(2-dimethylaminoethy-lpropionyl phenyl] -N-acetylglycine hyrochloride. Water ml.) is added and insoluble material is filtered 06. To the solution is added 7.5 g. of sodium bicarbonate, and the basic solution is heated for 17 minutes on the steam bath. Acidification with hydrochloric acid precipitates the product, which is recrystallized from aqueous isopropyl alcohol to yield 1.9 g. of N-(4-methacryloylphenyl)-N-acetylglycine, M.P. 205- 207 C.
Analysis f0! C H NO .Calculatd: C, H, 5.79; N, 5.36. Found: C, 64.45; H, 5.93; N, 5.31.
EXAMPLE 5 N- [2,3-dimethyl-4- (Z-methylenebutyryl) phenyl] glycine STEP A.-2,3-DIMETHYL4 -Al\II-NOBUTYR OPHENONE Butyryl chloride (18 g., 0.168 mole) is added drop- Wise during one hour to a stirred mixture of 13.7 g. (0.084 mole) of N-acetyl-2,3-dimethylaniline and 45 g. (0.336 mole) of aluminum chloride. The mixture is heated and stirred 3 hours on the steam bath, then cooled and poured into a mixture of ice and hydrochloric acid. The product, 2',3 dimethyl 4'-acetamidobutyrophenone, is taken up in benzene; the benzene is evaporated, 90 ml. of 6 N hydrochloric acid is added, and the mixture heated. with stirring on the steam bath for 1.5 hours to effect hydrolysis. Basification of the resulting mixture with a 40% sodium hydroxide solution precipitates the crystalline amine, which is repeatedly recrystallized from cyclohexanebenzene to obtain 3.8 g. of 2,3-dimethyl-4'-aminobutyrophenone, MP. 74-77.5 C.
Analysis for C Hi N0.-Calculated: N, 7.32. Found: N, 7.24.
STEP B.ETHYL N-(2,3 DIMETHYL-4vBUTYRYL- PHENYL) GLYCI-NATE Analysis for C H NO .Calculated: N, 5.05. Found;
STEP C.N- 2,3DIMETHYL--BUTYRYLPHENYL) GLYCINE Ethyl N-(2,3-dimethyl-4-butyrylphenyl)glycinate (49.8 g., 0.18 mole) is stirred and heated 0.5 hour on the steam bath with 1.0 l. of 5% sodium hydroxide solution. The resulting solution is cooled and acidified with hydrochloric acid to precipitate the product, which is then purified by being redissolved in dilute sodium hydroxide solution and reprecipitated with hydrochloric acid. There is thus, obtained 44.5 g. of N-(2,3-dimethyl-4-butyrylphenyl)glycine, M.P. 148l51 C.
Analysis for C ,,H NO .-Ca1culated: N, 5.62. Found: N, 5.52.
STEP or u-tas-omncrnyn 4. 2 DIMETHYLAMINO- METHYLBUTYRYL) PHENYL] GLYCINE HYDROCHLO- RIDE A mixture of21.1 g. (0.085 mole) of N-(2,3-dimethyl 4-butyrylphenyl)glycine, 3.8 g. (0.127 mole) of paraformaldehyde, 7.6 g. (0.093 mole) of dimethylamine hydrochloride and 1.5 m1. of acetic acid is heated one hour on the steam bath. The resulting pasty mass is stirred with 150 ml. of boiling isopropyl alcohol. The mixture is cooled and the product is collected. There is thus obtained 10 g.
A solution of 5.5 g. (0.016 mole) of N-[2,3-dimethyl- 4- 2-dimethylaminomethylbutyryl) phenyl] glycine hydrochloride in 100 ml. of saturated sodium bicarbonate solution is allowed to stand days at room temperature. Acidification with hydrochloric acid precipitates 1.8 g. of the product, M.P. 100-105 C. Recrystallization from cyclohexane-benzene yields pure N-[2,3-dimethyl-4-(2- methylenebutyryl)phenyl]glycine, M.P. 103106 C.
Analysis for C H NO .Calculated: C, 68.94; H, 7.33; N, 5.36. Found: C, 68.92; H, 7.57; N, 5.27.
By substituting the appropriate N-carboxyalkyl-4-(2- sec.-aminomethylalkanoyl)aniline hydrochloride reactant (II) for the N-[3-chloro-4-(Z-dimethylaminomethylpropionyl)phenyl]sarcosine hydrochloride of Example 2, Step C, and following substantially the procedure described therein, the corresponding N-carboxyalkyl-(Z- methylenealkanoyl)aniline products are prepared. The following equation and accompanying table depict the reaction described in the foregoing example and illustrate the starting materials and final products produced thereby:
It is apparent from the foregoing description that the N carboxyalkyl (2 methylenea'lkanoyl)aniline compounds of the present invention constitute a very valuable class of compounds which has not been prepared heretofore. One skilled in the art will also appreciate that the processes disclosed in the above examples are merely illustrative and are capable of wide variation and modification without departing from the spirit of this invention.
What is claimed is:
1. A compound of the formula:
H i H wherein R represents a member selected from the group consisting of lower alkyl, cycloalkyl, trifluoromethyl sub stituted lower alkyl,
(X011m (X0111 and wherein the radical X is a member selected from the group consisting of hydrogen, halogen, lower alkyl and lower alkoxy, R is a member selected from the group consisting of hydrogen, lower alkyl and lower alkanoyl, X is a member selected from the group consisting of H M L f El base lgiydrogen, halogen, lower alkyl and, taken together, two N CDHEH OOH 3O radicals on ad acent carbon atoms of the benzene ring 5 may be combined to form an hydrocarbylene chain contaming four carbon atoms between their points of attach- N HCl ment, m, in each occurrence, is an integer having a value of 13 and n, in each occurrence, is an integer having a 1 value of 1-5.
0 X3 2 R O 2. A compound ofxtahe itgormula: R t lsc.m. 0.. I
CH2 Rf|JC-- 5 NC..Hz..-COH
r out TABLE 1 Example R R1 R1- R3 X2 X3 C Hg s CH3 CH0 -CH3 CH; H 01 CI-I2 7 -CzH5 H CH: CH; H C1 OHZ s C2H5 H CH3 CH3 Cl 01 CH; 9 CH H CH3 OH; H 01 -CH- JH 1O CH5 H CH; -CH3 OH=CHCH=CH OH2- 11 -CHCH3 H CzH o2H5 H 01 0H,
12 CH-CH3 H (O H2)5 C1 C1 CH- 13 -CHz-CF3 H oH3 CH3 CH3 CH; CH 14 CHCH3 H -CH3 CH3 H CH3 OH2 15 CzH5 H O2Hs C2H5 Cl CHa CH5- 16 C1H5 H (CHz)4- GHQ 01 CHZ 17 H -CH3 -CH3 H C1 OH- .1... 18 41m CH: CH3 CH3 H 01 CH1 GHQ-CH2 19 Cfi CH: H CHa CH3 H Cl CH2 oHr-cHs wherein R represents lower alkyl, R is a member selected from the group consisting of hydrogen, lower alkyl and lower alkanoyl, X and X each represents similar or dissimilar radicals selected from the group consisting of hydrogen, halogen and lower. alkyl and n is an integer having a value of 1-2.
3. A compound of the formula:
wherein R is lower alkyl, X is halogen and n is an integer having a value of 1-2.
4. A compound of the formula:
wherein R is lower alkyl, R is lower alkanoyl, X is halogen and n is an integer having a value of 1-2.
2 6. A compound of the formula:
0 R o n-o-o r ronnnii o H wherein R is lower alkyl, R is lower alkanoyl and n is an integer having a value of 1-2.
7. A compound of the formula:
wherein R is lower alkyl, X and X represent lower alkyl and n is an integer having a value of 1-2.
3. N-(3-ch1oro-4-methacryloylphenyl)glycine.
9. N-(3-chl0ro-4-methacryloylphenyl)sarcosine.
10. N-(3-chloro 4 methacryloylphenyl) N acetylglycine.
11. N- (4-methacryloylphenyl) -N-acetyl glycine.
12. N-[2,3-dimethy1 4 (Z-methylenebutyryl)phenyl] glycine.
References Cited UNITED STATES PATENTS 6/1966 Bolhofer et a1 260-519 OTHER REFERENCES Advanced Organic Chemistry, E. E. Royals, 1961, Prentice-Hall, Inc., page 789 relied on.

Claims (1)

1. A COMPOUND OF THE FORMULA:
US348256A 1964-02-28 1964-02-28 Nu-carboxyalkyl-(2-methylenealkanoyl) aniline compounds Expired - Lifetime US3352904A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US348256A US3352904A (en) 1964-02-28 1964-02-28 Nu-carboxyalkyl-(2-methylenealkanoyl) aniline compounds
FR4435A FR1458113A (en) 1964-02-28 1965-02-04 Process for the preparation of aniline derivatives
GB5359/65A GB1095236A (en) 1964-02-28 1965-02-08 N-carboxyalkyl-(2-methylene alkanoyl) aniline derivatives
BR167298/65A BR6567298D0 (en) 1964-02-28 1965-02-18 PROCESS FOR PREPARING ANILINE DERIVATIVES
CH239265A CH473090A (en) 1964-02-28 1965-02-22 Process for the preparation of aniline derivatives
NL6502404A NL6502404A (en) 1964-02-28 1965-02-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US348256A US3352904A (en) 1964-02-28 1964-02-28 Nu-carboxyalkyl-(2-methylenealkanoyl) aniline compounds

Publications (1)

Publication Number Publication Date
US3352904A true US3352904A (en) 1967-11-14

Family

ID=23367244

Family Applications (1)

Application Number Title Priority Date Filing Date
US348256A Expired - Lifetime US3352904A (en) 1964-02-28 1964-02-28 Nu-carboxyalkyl-(2-methylenealkanoyl) aniline compounds

Country Status (6)

Country Link
US (1) US3352904A (en)
BR (1) BR6567298D0 (en)
CH (1) CH473090A (en)
FR (1) FR1458113A (en)
GB (1) GB1095236A (en)
NL (1) NL6502404A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545996A (en) * 1983-10-14 1985-10-08 Laboratoire L. Lafon N-(4-Acetylaminophenacyl)amine derivatives useful as pharmaceuticals
US4677228A (en) * 1985-02-09 1987-06-30 Smith Kline & French Laboratories, Ltd. Chemical process
US5344892A (en) * 1993-07-02 1994-09-06 Enichem S.P.A. Polyester compositions with improved crystallization rate
US5506226A (en) * 1993-04-19 1996-04-09 Alcon Laboratories, Inc. Ethacrynic acid-like compounds and use thereof to treat glaucoma
WO2019013899A1 (en) 2017-07-13 2019-01-17 Exxonmobil Chemical Patents Inc. Polyester compositions, and process for making articles therefrom

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255242A (en) * 1961-11-14 1966-06-07 Merck & Co Inc (alpha-alkylideneacyl)naphthyloxy monocarboxylic acids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255242A (en) * 1961-11-14 1966-06-07 Merck & Co Inc (alpha-alkylideneacyl)naphthyloxy monocarboxylic acids

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545996A (en) * 1983-10-14 1985-10-08 Laboratoire L. Lafon N-(4-Acetylaminophenacyl)amine derivatives useful as pharmaceuticals
US4677228A (en) * 1985-02-09 1987-06-30 Smith Kline & French Laboratories, Ltd. Chemical process
US5506226A (en) * 1993-04-19 1996-04-09 Alcon Laboratories, Inc. Ethacrynic acid-like compounds and use thereof to treat glaucoma
US5650541A (en) * 1993-04-19 1997-07-22 Alcon Laboratories, Inc. Ethacrynic acid-like compounds and use thereof to treat glaucoma
US5344892A (en) * 1993-07-02 1994-09-06 Enichem S.P.A. Polyester compositions with improved crystallization rate
WO2019013899A1 (en) 2017-07-13 2019-01-17 Exxonmobil Chemical Patents Inc. Polyester compositions, and process for making articles therefrom
US10662325B2 (en) 2017-07-13 2020-05-26 Exxonmobil Chemical Patents Inc. Polyester compositions, and process for making articles therefrom

Also Published As

Publication number Publication date
NL6502404A (en) 1965-08-30
FR1458113A (en) 1966-11-10
GB1095236A (en) 1967-12-13
CH473090A (en) 1969-05-31
BR6567298D0 (en) 1973-09-18

Similar Documents

Publication Publication Date Title
US4087544A (en) Treatment of cranial dysfunctions using novel cyclic amino acids
US4024175A (en) Cyclic amino acids
US4009273A (en) Substituted 10,11-dihydro-5,10-imino-[5H] dibenzo (a,d)-cycloheptene
US3313848A (en) Anthranilic acids and derivatives
US3542850A (en) Substituted anilides
SU1195903A3 (en) Method of producing 1-phenyl-2-aminocarbonylindole compounds or their salts of acid connection
US3621043A (en) N-substituted octadecadienoic acid amides as cholesterol lowering agents
US3352904A (en) Nu-carboxyalkyl-(2-methylenealkanoyl) aniline compounds
US3864385A (en) New 5-Aminoisophthalic Acid Derivatives, Salts And Esters Thereof And Methods For Their Preparation
US3551419A (en) Amino acid amides and process for their production
US2666050A (en) Process of producing them
SU747419A3 (en) Method of producing derivatives of amino acids or their salts or optical isomers
JPH02306947A (en) Preparation of chiral bata-amino acid
US2772280A (en) Synthesis of 4-amino-3-isoxazolidone and its derivatives
US3070628A (en) 4-allyloxybenzylamines
US3408396A (en) alpha-cyclohexyl-3, 4-disubstituted-phenyl acetamides
SU1292666A3 (en) Method of producing hydrochloride or acid fumarate 1,1-di(n-propyl)-n-butylamine
US3058992A (en) Intermediates for the preparation of
US3729509A (en) (mono-and diacylvinyl)aryl alkanoic(and alkenoic)acids
US4119637A (en) 4-Hydroxymethyl-2-pyrrolidinones
NO832810L (en) 1,3-DIOKSOLO (4,5-G) -KINOLINES AND PROCEDURES FOR THEIR PREPARATION.
NO135092B (en)
US2290281A (en) Substituted amine derivatives
US3114756A (en) Tetracyano-benzoquinone-(1, 4) and process for preparing it
US3337578A (en) 2, 2'-alkylenebisbenzimidazoles